E-intervention on Subclinical Fear of Cancer Recurrence
Recruiting
N/A
Interventional Study
Cancer
Psychooncology
Fear of Cancer Recurrence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 48 (estimated)
- Sponsor
- The University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Cantonese- or Mandarin-speaking Chinese cancer survivors
* recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
* had recently completed surgery as primary treatment
* have completed hospital-based adjuvant treatments (including radiotherapy…
Contacts